Skip to main content
Torrent Pharmaceuticals Ltd. logo

Torrent Pharmaceuticals Ltd. — Investor Relations & Filings

Ticker · TORNTPHARM ISIN · INE685A01028 LEI · 335800NA6HK275RIJE13 BSE.NS Manufacturing
Open in API
Filings indexed 1,762 across all filing types
Latest filing 2024-04-01 Board/Management Inform…
Country IN India
Listing BSE.NS TORNTPHARM

About Torrent Pharmaceuticals Ltd.

https://www.torrentpharma.com

Torrent Pharmaceuticals Ltd. is a research-driven organization focused on the development, manufacturing, and marketing of generic formulations. The company holds a significant position in therapeutic areas such as cardiovascular, central nervous system, gastrointestinal, diabetology, and anti-infective treatments. It has strategically expanded its portfolio into dermatology, nephrology, and pain management through targeted acquisitions. The firm operates across multiple international markets, supported by advanced research and development centers and manufacturing facilities that adhere to global regulatory standards. Its core operations prioritize chronic therapy leadership and the provision of high-quality healthcare solutions through a robust pipeline of generic and value-added medicines.

Recent filings

Filing Released Lang Actions
Change in Director(s)
Board/Management Information Classification · 100% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) regarding the cessation of directors of the company Torrent Pharmaceuticals Limited. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which governs disclosures related to changes in directors or key managerial personnel. The content details the completion of tenure and stepping down of specific directors, with no financial data or report attached. This fits the category of announcements about changes in the company's board of directors. Therefore, the document is best classified as Board/Management Information (MANG). The document length and content confirm it is not a report or announcement of a report but a direct regulatory disclosure about management changes.
2024-04-01 English
Retirement
Board/Management Information Classification · 100% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) regarding the cessation of directors of the company Torrent Pharmaceuticals Limited. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of events or information including changes in directors. The content details the completion of tenure and stepping down of specific directors, with dates and brief notes. There is no financial data, no discussion of financial results, no audit information, no voting results, no dividend information, and no mention of any report publication. The document is clearly an announcement of changes in the company's board of directors. Therefore, the appropriate classification is Board/Management Information (MANG). The document length (4549 characters) and content confirm it is not a brief announcement or a report publication notice but a substantive disclosure of management changes.
2024-04-01 English
Intimation of the Closure of Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal letter from Torrent Pharmaceuticals Limited addressed to stock exchanges (BSE and NSE) informing about the closure of the trading window for designated persons. It references the company's Code of Conduct and SEBI regulations, and specifies the trading window closure period related to the submission of the Audited Financial Results for the fiscal year ending 31st March 2024. The document does not contain any financial data, results, or detailed report content. It is an announcement related to trading restrictions around the financial results release, not the financial report itself. The document length is short (1446 characters), and it serves as a regulatory notification rather than a report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such compliance and regulatory announcements that do not fit other specific categories.
2024-03-27 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a short notice informing about the closure of the trading window for designated persons in accordance with the company's code of conduct and SEBI regulations. It mentions the closure period starting from April 1, 2024, until 48 hours after the submission of the audited financial results for the fiscal year ending March 31, 2024. There is no financial data, detailed report, or analysis included. The document is an announcement related to trading restrictions rather than a financial report or detailed filing. Given its nature and length (1446 characters), it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-03-27 English
Intimation of loss of share certificates
Regulatory Filings
2024-03-13 English
Loss of Share Certificates
Regulatory Filings
2024-03-13 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.